# PTC124 for Cystic Fibrosis

> **NCT00234663** · PHASE2 · COMPLETED · sponsor: **PTC Therapeutics** · enrollment: 24 (—)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** PTC124

## Key facts

- **NCT ID:** NCT00234663
- **Lead sponsor:** PTC Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 24 (—)
- **Last updated:** 2009-01-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234663, "PTC124 for Cystic Fibrosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00234663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*